FLT3 and acute myeloid leukemia: In terms of molecular associations, co-mutational analysis reveals a lower mutational rate than AML with a normal karyotype, with an enrichment of mutations in genes of the RAS pathway (e.g., KRAS, NRAS, and PTPN11, up to 30%) and FLT3 (8–14%).